☰

Martin S. Hoagland, Ph.D. - Publications

Affiliations: 
2005 University of Kentucky, Lexington, KY 
Area:
Pharmacology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Wu R, Zhang L, Hoagland MS, Swanson HI. Lack of the aryl hydrocarbon receptor leads to impaired activation of AKT/protein kinase B and enhanced sensitivity to apoptosis induced via the intrinsic pathway. The Journal of Pharmacology and Experimental Therapeutics. 320: 448-57. PMID 17018692 DOI: 10.1124/Jpet.106.111773  0.344
2006 Putt KS, Chen GW, Pearson JM, Sandhorst JS, Hoagland MS, Kwon JT, Hwang SK, Jin H, Churchwell MI, Cho MH, Doerge DR, Helferich WG, Hergenrother PJ. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nature Chemical Biology. 2: 543-50. PMID 16936720 DOI: 10.1038/Nchembio814  0.425
2005 Hoagland MS, Hoagland EM, Swanson HI. The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor. The Journal of Pharmacology and Experimental Therapeutics. 314: 603-10. PMID 15843497 DOI: 10.1124/Jpet.105.084186  0.44
Show low-probability matches.